Cybin (HELP) Assets Average (2021 - 2026)
Cybin (HELP) posted quarterly Assets Average of $270.6 million for Q1 2026, up 49.63% year-on-year from $180.9 million in Q1 2025, and up 14.83% on a QoQ basis from $235.7 million in Q4 2025.
Cybin (HELP) Assets Average (2021 - 2026) Analysis & Trends
Cybin (HELP) has reported Assets Average for 6 consecutive years, with $270.6 million the latest figure, recorded in Q1 2026.
- Quarterly Assets Average rose 49.63% year-over-year to $270.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $270.6 million (up 49.63% YoY) and the FY2026 annual result came in at $215.5 million, up 6.69% from the prior year.
- Assets Average climbed to $270.6 million in Q1 2026 per HELP's latest filing, from $235.7 million in the prior quarter.
- Over the last five years, Assets Average for HELP reached as high as $270.6 million in Q1 2026 and fell as low as $39.3 million in Q1 2023.
- A 5-year average of $149.6 million and a median of $183.9 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average tumbled 38.66% — and 2024, when it jumped 373.23%.
- Year by year, Assets Average stood at $48.9 million in 2022, then surged by 41.52% to $69.1 million in 2023, then jumped by 170.37% to $186.9 million in 2024, then rose by 26.08% to $235.7 million in 2025, then gained by 14.83% to $270.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $270.6 million, $235.7 million, and $196.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | 270.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 270.64 Mn |
| Dec 31, 2025 | 235.68 Mn |
| Sep 30, 2025 | 196.03 Mn |
| Jun 30, 2025 | 195.52 Mn |
| Mar 31, 2025 | 180.87 Mn |
| Dec 31, 2024 | 186.92 Mn |
| Sep 30, 2024 | 200.23 Mn |
| Jun 30, 2024 | 216.13 Mn |
| Mar 31, 2024 | 159.71 Mn |
| Dec 31, 2023 | 69.14 Mn |
| Sep 30, 2023 | 50.26 Mn |
| Jun 30, 2023 | 45.67 Mn |
| Feb 28, 2023 | 39.26 Mn |
| Dec 31, 2022 | 48.85 Mn |
| Dec 31, 2021 | 79.64 Mn |
| Sep 30, 2021 | 75.59 Mn |
| Jun 30, 2021 | 70.08 Mn |